The European Medicines Agency (EMA) announced Tuesday that Janssen, a division of Johnson & Johnson, has submitted an application for conditional marketing authorization for its one-dose vaccine ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The Food and Drug Administration (FDA) has announced that it is ...

Health Minister Stephen Donnelly has confirmed that the National Immunisation Advisory Committee (NIAC) has recommended to Government that the AstraZeneca and Janssen (Johnson & Johnson) vaccines can ...

The US Food and Drug Administration (FDA) has issued an emergency use authorization for the COVID-19 vaccine developed by Janssen, a division of Johnson & Johnson. “The authorization of this vaccine ...

Both neutralizing antibodies and antibody effector functions are needed for protection against re-infection with respiratory syncytial virus (RSV), which may explain why it has been challenging to ...

The one-dose coronavirus vaccine Janssen will not arrive in Estonia this week. The manufacturer has experienced supply issues all summer. Estonia has had no deliveries of the vaccine for several weeks ...

"(The) EMA's safety committee (PRAC) concluded that a warning about unusual blood clots with low blood platelets should be added to the product information for COVID-19 Vaccine Janssen," the agency ...

LONDON — The European Medicines Agency said Tuesday the Johnson & Johnson Covid-19 vaccine has possible links to rare blood clot incidents, but reiterated that its benefits still outweighed the risks.